Skip to main content
SpringerLink
Log in
Book cover

Anesthesia for the New Millennium pp 207–212Cite as

Controversies Regarding Sevoflurane & Desflurane Toxicity

  • Chapter

  • 134 Accesses

Part of the book series: Developments in Critical Care Medicine and Anesthesiology ((DCCA,volume 34))

Abstract

The new anesthetics, desflurane and sevoflurane, differ from their predecessors in that these new anesthetics are halogenated solely with fluorine. The absence of chlorine and bromine increases the stability of these anesthetics, but the increased stability is not perfect. Thus, we need to consider the potential of each to be metabolized in the body or degraded by strong base (carbon dioxide absorbents) into toxic compounds.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Sutton TS, Koblin DD, Gruenke LD, Weiskopf RB, Rampil IJ, Waskell L, Eger EI, II: Fluoride metabolites following prolonged exposure of volunteers and patients to desflurane. Anesth Analg 1991; 73:180–5

    Article  PubMed  CAS  Google Scholar 

  2. Holaday DA, Smith FR: Clinical characteristics and biotransformation of sevoflurane in healthy human volunteers. Anesthesiology 1981; 54:100–6

    Article  PubMed  CAS  Google Scholar 

  3. Higuchi H, Sumikura H, Sumita S, Arimura S, Takamatsu F, Kanno M, Satoh T: Renal function in patients with high serum fluoride concentrations after prolonged sevoflurane anesthesia. Anesthesiology 1995; 83:449–58

    Article  PubMed  CAS  Google Scholar 

  4. Mazze RI, Jamison R: Renal effects of sevoflurane (editorial). Anesthesiology 1995; 83:443–5

    Article  PubMed  CAS  Google Scholar 

  5. Goldberg ME, Cantillo J, Larijani GE, Torjman M, Vekeman D, Schieren H: Sevoflurane versus isoflurane for maintenance of anesthesia: are serum inorganic fluoride ion concentrations of concern? Anesth Analg 1996; 82:1268–72

    PubMed  CAS  Google Scholar 

  6. Morio M, Fujii K, Satoh N, Imai M, Kawakami U, Mizuno T, Kawai Y, Ogasawara Y, Tamura T, Negishi A, Kumagai Y, Kawai T: Reaction of sevoflurane and its degradation products with soda lime. Toxicity of the by-products. Anesthesiology 1992; 77:1155–64

    Article  PubMed  CAS  Google Scholar 

  7. Frink EJ, Jr, Malan TP, Morgan SE, Brown EA, Malcomson M, Brown BR, Jr: Quantification of the degradation products of sevoflurane in two CO2 absorbents during low-flow anesthesia in surgical patients. Anesthesiology 1992; 77:1064–9

    Article  PubMed  Google Scholar 

  8. Gonsowski CT, Laster MJ, Eger EI, II, Ferrell LD, Kerschmann RL: Toxicity of compound A in rats. Effect of increasing duration of administration. Anesthesiology 1994; 80:566–73

    Article  PubMed  CAS  Google Scholar 

  9. Gonsowski CT, Laster MJ, Eger EI, II, Ferrell LD, Kerschmann RL: Toxicity of compound A in rats. Effect of a 3-hour administration. Anesthesiology 1994; 80:556–65

    Article  PubMed  CAS  Google Scholar 

  10. Keller KA, Callan C, Prokocimer P, Delgado-Herrera L, Friedman MB, Hoffman GM, Wooding WL, Cusick PK, Krasula RW: Inhalation toxicity study of a haloalkene degradant of sevoflurane, compound A (PIFE), in Sprague-Dawley rats. Anesthesiology 1995; 83:1220–32

    Article  PubMed  CAS  Google Scholar 

  11. Newton PE, Friedman MB, Hulsebos LH, Rajasekaran D, Walter GL: Acute inhalation toxicity of sevoflurane with 75 or 100 ppm compound A (abstract). The Toxicologist 1998; 42:254

    Google Scholar 

  12. Mazze RI: The safety of sevoflurane in humans. Anesthesiology 1992 (editorial); 77:1062–3

    Article  PubMed  CAS  Google Scholar 

  13. Eger EI, II, Koblin DD, Bowland T, Balea M, Ionescu P, Laster MJ, Fang Z, Gong D, Sonner J, Weiskopf RB: Nephrotoxicity of sevoflurane vs. desflurane anesthesia in volunteers. Anesth Analg 1997; 84:160–8

    PubMed  CAS  Google Scholar 

  14. Eger EI, II, Gong D, Koblin DD, Bowland T, Ionescu P, Laster MJ, Weiskopf RB: Dose-related biochemical markers of renal injury after sevoflurane vs. desflurane anesthesia in volunteers. Anesth Analg 1997; 85:1154–63

    PubMed  CAS  Google Scholar 

  15. Bito H, Ikeuchi Y, Ikeda K: Effects of low-flow sevoflurane anesthesia on renal function. Comparison with high-flow sevoflurane anesthesia and low-flow isoflurane anesthesia. Anesthesiology 1997; 86:1231–7

    Article  PubMed  CAS  Google Scholar 

  16. Kharasch ED, Frink EJ, Jr, Zagar R, Bowdle TA, Artru A, Nogami WM: Assessment of low-flow sevoflurane and isoflurane effects on renal function using sensitive markers of tubular toxicity. Anesthesiology 1997; 86:1238–53

    Article  PubMed  CAS  Google Scholar 

  17. Cantillo J, Goldberg ME, Gratz I, Afsharvand M, Insinga F: Nephrotoxicity of compound A and/or inorganic fluoride ion (F) in normal volunteers. Anesthesiology 1997; 87:A1136

    Article  Google Scholar 

  18. Ebert TJ, Frink EJ, Kharasch ED: Absence of biochemical evidence for renal and hepatic dysfunction after 8 hours of 1.25 minimum alveolar concentration sevoflurane anesthesia in volunteers. Anesthesiology 1998; 88:601–10

    Article  PubMed  CAS  Google Scholar 

  19. Eger EI, II, Laster MJ, Winegar R, Han C, Gong D: Compound A induces sister chromatid exchanges in Chinese hamster ovary cells. Anesthesiology 1997; 86:918–22

    Article  PubMed  CAS  Google Scholar 

  20. Kandel L, Laster MJ, Eger EI, II, Kerschmann RL, Martin J: Nephrotoxicity in rats undergoing a 1-hour exposure to Compound A. Anesth Analg 1995; 81:559–63

    PubMed  CAS  Google Scholar 

  21. Kharasch ED, Thorning D, Garton K, Hankins DC, Kilty CG: Role of renal cysteine conjugate b-lyase in the mechanism of compound A nephrotoxicity in rats. Anesthesiology 1997; 86:160–71

    Article  PubMed  CAS  Google Scholar 

  22. Jin L, Baillie TA, Davis MR, Kharasch ED: Nephrotoxicity of sevoflurane compound A [fluoromethyl-2,2-difluoro-l-(trifluoro-methyl) vinyl ether] in rats: Evidence for glutathione and cysteine conjugate formation and the role of renal cysteine conjugate b-lyase. Biochem Biophy Res Comm 1995; 210:498–506

    Article  CAS  Google Scholar 

  23. Martin JL, Laster MJ, Kandel L, Kerschmann RL, Reed GF, Eger EI, II: Metabolism of compound A by renal cysteine-S-conjugate b-lyase is not the mechanism of compound A-induced renal injury in the rat. Anesth Analg 1996; 82:770–4

    PubMed  CAS  Google Scholar 

  24. Martin JL, Kandel L, Laster M, Kerschmann RL, Eger EI, II: Studies of the mechanism of the nephrotoxicity of compound A in rats. J Anesth 1997; 11:32–7

    Article  Google Scholar 

  25. Eger EI, II, Martin JL: Do the benefits of sevoflurane outweigh the risks? J Anesth 1997; 11:316–7

    Article  Google Scholar 

  26. Fang ZX, Eger EI, II, Laster MJ, Chortkoff BS, Kandel L, Ionescu P: Carbon monoxide production from degradation of desflurane, enflurane, isoflurane, halothane, and sevoflurane by soda lime and Baralyme®. Anesth Analg 1995; 80:1187–93

    PubMed  CAS  Google Scholar 

  27. Davies MW, Potter FA: Carbon monoxide, soda lime and volatile agents (letter). Anaesthesia 1996; 51:90

    Article  PubMed  CAS  Google Scholar 

  28. Baum J, Sachs G, Driesch Cvd, Stanke H-G: Carbon monoxide generation in carbon dioxide absorbents. Anesth Analg 1995; 81:144–6

    PubMed  CAS  Google Scholar 

  29. Woehlck HJ, Dunning M, III, Connolly LA: Reduction in the incidence of carbon monoxide exposures in humans undergoing general anesthesia. Anesthesiology 1997; 87:228–34

    Article  PubMed  CAS  Google Scholar 

  30. Watanabe K, Hatakenaka S, Ikemune K, Chigyo Y, Kubozono T, Arai T: A case of suspected liver dysfunction induced by sevoflurane anesthesia. Masui 1993; 42:902–5

    PubMed  CAS  Google Scholar 

  31. Shichinohe Y, Masuda Y, Takahashi H, Kotaki M, Omote T, Shichinohe M, Namiki A: A case of postoperative hepatic injury after sevoflurane anesthesia. Masui 1992; 41:1802–5

    PubMed  CAS  Google Scholar 

  32. Ogawa M, Doi K, Mitsufuji T, Satoh K, Takatori T: Drug induced hepatitis following sevoflurane anesthesia in a child. Masui 1991; 40:1542–5

    PubMed  CAS  Google Scholar 

  33. Enokibori M, Miyazaki Y, Hirota K, Sasai S: A case of postoperative fulminant hepatitis after sevoflurane anesthesia. Jap J Anesth 1992; 41:S94

    Google Scholar 

  34. Omori H, Seki S, Kanaya N, Imasaki H, Namiki A: A case of postoperative liver damage after isoflurane anesthesia followed by sevoflurane anesthesia. J Jap Soc Clin Anesth 1994; 14:68–71

    Article  Google Scholar 

  35. Frink EJ, Jr, Green WB, Jr, Brown EA, Malcomson M, Hammond LC, Valencia FG, Brown BR, Jr: Compound A concentrations during sevoflurane anesthesia in children. Anesthesiology 1996; 84:566–71

    Article  PubMed  CAS  Google Scholar 

  36. Martin JL, Plevak DJ, Flannery KD, Charlton M, Poterucha JJ, Humphreys CE, Derfus G, Pohl LR: Hepatotoxicity after desflurane anesthesia. Anesthesiology 1995; 83:1125–9

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Edmond I. Eger II
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Anesthesiology, The University of Utah Medical School, Salt Lake City, Utah, USA

    Theodore H. Stanley  & Talmage D. Egan  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Eger, E.I. (1999). Controversies Regarding Sevoflurane & Desflurane Toxicity. In: Stanley, T.H., Egan, T.D. (eds) Anesthesia for the New Millennium. Developments in Critical Care Medicine and Anesthesiology, vol 34. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4566-4_22

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-4566-4_22

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-5935-0

  • Online ISBN: 978-94-011-4566-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation